参考文献/References:
[1] Viola A,Monticone S,Burrello J,et al.Renin and aldosterone measurements in the management of arterial hypertension[J].Horm Metab Res,2015,47(6):418-426.DOI:10.1055/s-0035-1548868.
[2] Arnal JF,Cudek P,Plouin PF,et al.Recent advances in the investigation of the renin-angiotensin and cardiac natriuretic systems in patients with chronic heart insufficiency[J].Arch Mal Coeur Vaiss,1991,84(9):1273-1280.
[3] Plouin PF,Cudek P,Arnal JF,et al.Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension,congestive heart failure,and liver cirrhosis[J].Horm Res,1990,34(3-4):138-141.DOI:10.1159/000181813.
[4] Sealey JE,Gordon RD,Mantero F.Plasma renin and aldosterone measurements in low renin hypertensive states[J].Trends Endocrinol Metab,2005,16(3):86-91.DOI:10.1016/j.tem.2005.02.006.
[5] Galen FX,Devaux C,Atlas S,et al.New monoclonal antibodies directed against human renin.Powerful tools for the investigation of the renin system[J].J Clin Invest,1984,74(3):723-735.DOI:10.1172/JCI111488.
[6] Plouin PF,Cudek P,Arnal JF,et al.Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension,congestive heart failure,and liver cirrhosis[J].Horm Res,1990,34(3-4):138-141.DOI:10.1159/000181813.
[7] Sealey JE,Trenkwalder P,Gahnem F,et al.Plasma renin methodology:inadequate sensitivity and accuracy of direct renin assay for clinical applications compared with the traditional enzymatic plasma renin activity assay[J].J Hypertens,1995,13(1):27-30; discussion 31.
[8] Perschel FH,Schemer R,Seiler L,et al.Rapid screening test for primary hyperaldosteronism:ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays[J].Clin Chem,2004,50(9):1650-1655.DOI:10.1373/clinchem.2004.033159.
[9] Funder JW,Carey RM,Mantero F,et al.The management of primary aldosteronism:case detection,diagnosis,and treatment:An Endocrine Society Clinical Practice Guideline[J].J Clin Endocrinol Metab,2016,101(5):1889-1916.DOI:10.1210/jc.2015-4061.
[10] Morganti A,European study group for the validation of DiaSorin LIAISON Direct Renin Assay.A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin[J].J Hypertens,2010,28(6):1307-1312.DOI:10.1097/HJH.0b013e32833857ad.
[11] Lonati C,Bassani N,Gritti A,et al.Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension[J].J Hypertens,2014,32(3):627-634.DOI:10.1097/HJH.0000000000000076.
[12] Dorrian CA,Toole BJ,Alvarez-Madrazo S,et al.A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin[J].Ann Clin Biochem,2010,47(Pt 3):195-199.DOI:10.1258/acb.2010.009230.
[13] Wu VC,Kuo CC,Chang HW,et al.Diagnosis of primary aldosteronism:comparison of post-captopril active renin concentration and plasma renin activity[J].Clin Chim Acta,2010,411(9-10):657-663.DOI:10.1016/j.cca.2010.01.027.
[14] Unger N,Lopez Schmidt I,Pitt C,et al.Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass[J].Eur J Endocrinol,2004,150(4):517-523.DOI:10.1530/eje.0.1500517.
[15] Rossi GP,Barisa M,Belfiore A,et al.The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma[J].J Hypertens,2010,28(9):1892-1899.DOI:10.1097/HJH.0b013e32833d2192.
[16] Glinicki P,Jeske W,Bednarek-Papierska L,et al.The ratios of aldosterone / plasma renin activity(ARR)versus aldosterone / direct renin concentration(ADRR)[J].J Renin Angiotensin Aldosterone Syst,2015,16(4):1298-1305.DOI:10.1177/1470320313519487.
[17] Burrello J,Monticone S,Buffolo F,et al.Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism[J].J Hypertens,2016,34(5):920-927.DOI:10.1097/HJH.0000000000000880.
[18] Li T,Ma Y,Zhang Y,et al.Feasibility of screening primary aldosteronism by aldosterone-to-direct renin concentration ratio derived from chemiluminescent immunoassay measurement:diagnostic accuracy and cutoff value[J].Int J Hypertens,2019,2019:2195796.DOI:10.1155/2019/2195796.
[19] Ma L,Song Y,Mei M,et al.Age-related cutoffs of plasma aldosterone/renin concentration for primary aldosteronism screening[J].Int J Endocrinol,2018,2018:8647026.DOI:10.1155/2018/8647026.
[20] Nishikawa T,Omura M,Satoh F,et al.Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009[J].Endocr J,2011,58(9):711-721.DOI:10.1507/endocrj.ej11-0133.
[21] Young WF Jr.Diagnosis and treatment of primary aldosteronism:practical clinical perspectives[J].J Intern Med,2019,285(2):126-148.DOI:10.1111/joim.12831.
[22] Wang K,Hu J,Yang J,et al.Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism[J].J Clin Endocrinol Metab,2020,105(7):dgaa282.DOI:10.1210/clinem/dgaa282.
相似文献/References:
[1]高海静,温俊平.肾上腺醛固酮腺瘤术后临床转归的影响因素[J].国际内分泌代谢杂志,2016,36(01):58.[doi:10.3760/cma.j.issn.1673-4157.2016.01.015]
Gao Haijing,Wen Junping..Influence factors of postoperative clinical outcomes for patients with adrenal aldosteronoma[J].International Journal of Endocrinology and Metabolism,2016,36(06):58.[doi:10.3760/cma.j.issn.1673-4157.2016.01.015]
[2]钟珊,宋筱筱,徐小红.原发性醛固酮增多症分型诊断研究进展[J].国际内分泌代谢杂志,2020,40(05):327.[doi:10.3760/cma.j.cn121383-20200203-02006]
Zhong Shan,Song Xiaoxiao,Xu Xiaohong.Research progress of subtype diagnosis in primary hyperaldosteronism[J].International Journal of Endocrinology and Metabolism,2020,40(06):327.[doi:10.3760/cma.j.cn121383-20200203-02006]
[3]郑爱琳,宋颖,罗蓉,等.关于原发性醛固酮增多症诊治的常见误区[J].国际内分泌代谢杂志,2021,41(02):73.[doi:10.3760/cma.j.cn121383-20210119-01054]
Zheng Ailin,Song Ying,Luo Rong,et al.Misunderstandings in the diagnosis and treatment of primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2021,41(06):73.[doi:10.3760/cma.j.cn121383-20210119-01054]
[4]王慧萍,童安莉.原发性醛固酮增多症相关的基因突变研究进展[J].国际内分泌代谢杂志,2021,41(02):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
Wang Huiping,Tong Anli..Research progress on gene mutation related primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2021,41(06):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
[5]许媛 许岚 张丽华 李启富 杨淑敏.中国原发性醛固酮增多症诊断现状调查研究[J].国际内分泌代谢杂志,2022,42(04):288.[doi:10.3760/cma.j.cn121383-20201221-12058]
Xu Yuan,Xu Lan,Zhang Lihua,et al.Investigation on current status of diagnosis of primary aldosteronism in China[J].International Journal of Endocrinology and Metabolism,2022,42(06):288.[doi:10.3760/cma.j.cn121383-20201221-12058]
[6]谢梦晨,郭洋洋,黄金慧,等.原发性醛固酮增多症基因型与临床表型关系的研究进展[J].国际内分泌代谢杂志,2023,43(03):216.[doi:10.3760/cma.j.cn121383-20220307-03015]
Xie Mengchen,Guo Yangyang,Huang Jinhui,et al.Association of genotype and clinical phenotype of primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2023,43(06):216.[doi:10.3760/cma.j.cn121383-20220307-03015]
[7]王敏 杨宇宏 孙敏.原发性醛固酮增多症的组织病理学新分类及其意义[J].国际内分泌代谢杂志,2023,43(05):372.[doi:10.3760/cma.j.cn121383-20220604-06010]
Wang Min,Yang Yuhong,Sun Min..New histopathological classification of primary aldosteronism and its significance[J].International Journal of Endocrinology and Metabolism,2023,43(06):372.[doi:10.3760/cma.j.cn121383-20220604-06010]